- Home
- ZYME vs TGB Comparison
ZYME vs TGB Comparison
Compare ZYME & TGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- TGB
- Stock Information
- Founded
- ZYME 2003
- TGB 1966
- Country
- ZYME United States
- TGB Canada
- Employees
- ZYME N/A
- TGB N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- TGB Precious Metals
- Sector
- ZYME Health Care
- TGB Basic Materials
- Exchange
- ZYME Nasdaq
- TGB Nasdaq
- Market Cap
- ZYME 846.1M
- TGB 720.2M
- IPO Year
- ZYME 2017
- TGB N/A
- Fundamental
- Price
- ZYME $11.31
- TGB $2.03
- Analyst Decision
- ZYME Buy
- TGB
- Analyst Count
- ZYME 6
- TGB 0
- Target Price
- ZYME $19.50
- TGB N/A
- AVG Volume (30 Days)
- ZYME 553.2K
- TGB 14.8M
- Earning Date
- ZYME 05-08-2025
- TGB 05-01-2025
- Dividend Yield
- ZYME N/A
- TGB N/A
- EPS Growth
- ZYME N/A
- TGB N/A
- EPS
- ZYME N/A
- TGB N/A
- Revenue
- ZYME $93,384,000.00
- TGB $417,640,101.00
- Revenue This Year
- ZYME $26.29
- TGB $25.02
- Revenue Next Year
- ZYME $75.78
- TGB $32.20
- P/E Ratio
- ZYME N/A
- TGB N/A
- Revenue Growth
- ZYME 85.05
- TGB 7.89
- 52 Week Low
- ZYME $8.21
- TGB $1.67
- 52 Week High
- ZYME $17.70
- TGB $3.15
- Technical
- Relative Strength Index (RSI)
- ZYME 40.96
- TGB 45.88
- Support Level
- ZYME $10.86
- TGB $1.89
- Resistance Level
- ZYME $13.23
- TGB $2.04
- Average True Range (ATR)
- ZYME 0.56
- TGB 0.10
- MACD
- ZYME -0.10
- TGB -0.02
- Stochastic Oscillator
- ZYME 18.78
- TGB 27.00
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About TGB Taseko Mines Ltd.
Taseko Mines Ltd is a Canadian mining company. It is principally engaged in the production and sale of metals, as well as related activities, including exploration and mine development, within the province of British Columbia, Canada, and the State of Arizona, the United States. The Gibraltar, Aley, New Prosperity, Yellowhead properties are located in British Columbia whereas Florence copper is in central Arizona.